Think Team works on building academic and industry collaborations with a primary goal to drive innovation at Otsuka. The team comprises of a group of research scientists, postdocs, and data scientists focusing both on scientific and technology innovations in healthcare.
The data scientist will support translational research and/or technology development for drug discovery and clinical development, clinical trial operational efficiencies, digital assessments and health products, and other intelligent scientific/innovation information management tools.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is an innovative, fast-growing healthcare company that discovers and develops new compounds that address unanswered medical needs and advance human health. With a strong focus on neuroscience, oncology, and cardio-renal treatments, OPDC is dedicated to improving the health and quality of human life. For more information, visit www.otsuka-us.com.
OPDC is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd. The Otsuka Group employs approximately 42,000 people globally and its products are available in more than 80 countries worldwide. Otsuka welcomes you to visit its global website at https://www.otsuka.co.jp/en/.